Comparative Effectiveness of Secukinumab and Golimumab in Ankylosing Spondylitis: Assessed By Matching-Adjusted Indirect Comparison Using Pivotal Phase 3 Clinical Trial Data

被引：0
|
作者：
Maksymowych, Walter P. [1 ]
Choy, Ernest [2 ]
Yazici, Yusuf [3 ]
Walsh, Jessica A. [4 ]
Thom, Howard [5 ]
Kalyvas, Chrysostomos [6 ]
Fox, Todd [7 ]
Gandhi, Kunal [8 ]
Jugl, Steffen [7 ]
机构：
[1] Univ Alberta, Radiol & Diagnost Imaging, Edmonton, AB, Canada
[2] Cardiff Univ, Sect Rheumatol, Cardiff, S Glam, Wales
[3] NYU, Sch Med, New York, NY USA
[4] Univ Utah, Div Rheumatol, Salt Lake City, UT USA
[5] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England
[6] MAPI Grp, Real World Strategy & Analyt, Houten, Netherlands
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1546
引用
收藏
页数：3
相关论文
共 50 条
  • [1] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Maksymowych, W.
    Choy, E.
    Yazici, Y.
    Walsh, J.
    Thom, H.
    Kalyvas, C.
    Fox, T.
    Gandhi, K.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1301 - 1301
  • [2] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA
    Tahir, Hasan
    Maksymowych, Walter
    Choy, Ernest
    Yazici, Yusuf
    Walsh, Jessica
    Thom, Howard
    Kalyvas, Chrysostomos
    Fox, Todd
    Gandi, Kunal
    Jugl, Steffen
    RHEUMATOLOGY, 2018, 57
  • [3] Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on Pivotal Phase 3 Clinical Trial Data
    Maksymowych, Walter
    Strand, Vibeke
    Nash, Peter
    Thom, Howard
    Karabis, Andreas
    Gandhi, Kunal
    Porter, Brian
    Jugl, Steffen
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 914 - 915
  • [4] Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis As Assessed By Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data
    Maksymowych, Walter P.
    Strand, Vibeke
    Nash, Peter
    Thom, Howard
    Karabis, Andreas
    Gandhi, Kunal
    Porter, Brian
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND ADALIMUMAB IN ANKYLOSING SPONDYLITIS AS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON: AN ANALYSIS BASED ON ALL PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Maksymowych, W. P.
    Walsh, J.
    Thom, H.
    Kalyvas, C.
    Rosal, G. F.
    Porter, B.
    Gandhi, K.
    Jugl, S. M.
    VALUE IN HEALTH, 2017, 20 (09) : A935 - A935
  • [6] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND ADALIMUMAB IN ANKYLOSING SPONDYLITIS (AS) AS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC): AN ANALYSIS BASED ON ALL PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Nash, P.
    Maksymowych, W.
    Strand, V
    Thom, H.
    Karabis, A.
    Gandhi, K.
    Porter, B.
    Jugl, S.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 38 - 38
  • [7] Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison
    Maksymowych, Walter P.
    Strand, Vibeke
    Nash, Peter
    Yazici, Yusuf
    Thom, Howard
    Hunger, Matthias
    Kalyvas, Chrysostomos
    Gandhi, Kunal K.
    Porter, Brian
    Jugl, Steffen M.
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (04) : 216 - +
  • [8] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND INFLIXIMAB IN PSORIATIC ARTHRITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Strand, V.
    McInnes, I.
    Mease, P.
    Choy, E.
    Nash, P.
    Thom, H.
    Kalyvas, C.
    Gandhi, K.
    Pricop, L.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 957 - 957
  • [9] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND INFLIXIMAB IN PSORIATIC ARTHRITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA
    Kaul, Arvind
    Strand, Vibeke
    McInnes, Lain
    Mease, Philip
    Choy, Ernest
    Nash, Peter
    Thom, Howard
    Kalyvas, Chrysostomos
    Gandhi, Kunal
    Pricop, Luminita
    Jugl, Steffen
    RHEUMATOLOGY, 2018, 57
  • [10] SECUKINUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Maksymowych, W.
    Strand, V
    Baeten, D.
    Nash, P.
    Thom, H.
    Hunger, M.
    Gandhi, K.
    Richards, H.
    Jugl, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 782 - 782
12345